Large Burden of Stroke Incidence in People with Cardiac Disease: A Linked Data Cohort Study

References

• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Petersen P, Godtfredsen J. Risk factors for stroke in chronic atrial fibrillation. Eur Heart J. 1988;9(3):291–294. doi:10.1093/oxfordjournals.eurheartj.a062499
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. J Am Heart Assoc. 1991;22:983–988.
   Google Scholar
• Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312–318. doi:10.1161/01.STR.22.3.312
   PubMed Web of Science ®Google Scholar
• Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482. doi:10.1136/bmj.i4482
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi:10.1016/S0140-6736(16)30506-2
   PubMed Web of Science ®Google Scholar
• Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197–1206. doi:10.1001/jama.297.11.1197
   PubMed Web of Science ®Google Scholar
• Yiin GS, Howard DP, Paul NL, et al. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation. 2014;130(15):1236–1244. doi:10.1161/CIRCULATIONAHA.114.010942
   PubMed Web of Science ®Google Scholar
• Zeymer U, Senges J, Parhofer KG, Rother J. Risk factors and event rates in patients with atherothrombotic disease in Germany: results of the REACH registry. Dtsch Arztebl Int. 2008;105(45):769–775. doi:10.3238/arztebl.2008.0769
   PubMed Web of Science ®Google Scholar
• Sarink D, Nedkoff L, Briffa T, et al. Trends in age- and sex-specific prevalence and incidence of cardiovascular disease in Western Australia. Eur J Prev Cardiol. 2018;25(12):1280–1290. doi:10.1177/2047487318786585
   PubMed Web of Science ®Google Scholar
• Mitchell LB, Southern DA, Galbraith D, et al. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS 2 and CHA 2 DS 2 -VASc scores. Heart. 2014;100(19):1524–1530. doi:10.1136/heartjnl-2013-305303
   PubMed Web of Science ®Google Scholar
• Feigin VL, Stark BA, Johnson CO; Global Burden of Disease Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/S1474-4422(21)00252-0
   PubMed Web of Science ®Google Scholar
• Cordero A, Rodriguez-Manero M, Garcia-Acuna JM, et al. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome. Int J Cardiol. 2019;276:20–25. doi:10.1016/j.ijcard.2018.10.082
   PubMed Web of Science ®Google Scholar
• Hurskainen M, Tynkkynen J, Eskola M, Hernesniemi J. Incidence of stroke and mortality due to stroke after acute coronary syndrome. J Stroke Cerebrovasc Dis. 2022;31(12):106842. doi:10.1016/j.jstrokecerebrovasdis.2022.106842
   PubMed Web of Science ®Google Scholar
• Petersen JK, Butt JH, Yafasova A, et al. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. Eur Heart J. 2021;42(44):4553–4561. doi:10.1093/eurheartj/ehab575
   PubMed Web of Science ®Google Scholar
• Raposeiras-Roubin S, Dominguez-Erquicia P, Abu-Assi E, et al. Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation. Arch Cardiovasc Dis. 2022;115(8–9):448–456. doi:10.1016/j.acvd.2022.05.006
   PubMed Web of Science ®Google Scholar
• Andreasen C, Gislason GH, Kober L, et al. Incidence of ischemic stroke in individuals with and without aortic valve stenosis: a Danish retrospective cohort study. Stroke. 2020;51(5):1364–1371. doi:10.1161/STROKEAHA.119.028389
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen JM, Bond-Smith D, Seth RJ, et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J Am Heart Assoc. 2020;9(19):e016851. doi:10.1161/JAHA.120.016851
   PubMed Web of Science ®Google Scholar
• Son MK, Lim NK, Kim HW, Park HY. Risk of ischemic stroke after atrial fibrillation diagnosis: a national sample cohort. PLoS One. 2017;12(6):e0179687. doi:10.1371/journal.pone.0179687
   PubMed Web of Science ®Google Scholar
• Suzuki S, Yamashita T, Okumura K, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J. 2015;79(2):432–438. doi:10.1253/circj.CJ-14-1131
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association. Circulation. 2021;143(8):e254–e743. doi:10.1161/CIR.0000000000000950
   PubMed Web of Science ®Google Scholar
• Haast RA, Gustafson DR, Kiliaan AJ. Sex differences in stroke. J Cereb Blood Flow Metab. 2012;32(12):2100–2107. doi:10.1038/jcbfm.2012.141
   PubMed Web of Science ®Google Scholar
• Nedkoff L, Kelty EA, Hung J, Thompson SC, Katzenellenbogen JM. Differences in stroke risk and cardiovascular mortality for Aboriginal and other Australian patients with atrial fibrillation. Med J Aust. 2020;212(5):215–221. doi:10.5694/mja2.50496
   PubMed Web of Science ®Google Scholar
• Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139(11):893–900. doi:10.7326/0003-4819-139-11-200312020-00007
   PubMed Web of Science ®Google Scholar
• Rubboli A, Becattini C, Verheugt FW. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol. 2011;3(11):351–358. doi:10.4330/wjc.v3.i11.351
   PubMedGoogle Scholar
• Yong CM, Tremmel JA, Lansberg MG, Fan J, Askari M, Turakhia MP. Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation. J Am Heart Assoc. 2020;9(10):e015689. doi:10.1161/JAHA.120.015689
   PubMed Web of Science ®Google Scholar
• Wakai A, O’Neill JO. Emergency management of atrial fibrillation. Postgrad Med J. 2003;79(932):313–319. doi:10.1136/pmj.79.932.313
   PubMed Web of Science ®Google Scholar